Enthesitis-related arthritis
Overview
•ERA is a subtype of juvenile idiopathic arthritis (JIA) - part of the seronegative spondyloarthropathy family
•Strong HLA-B27 association (up to 80-90%); predilection for older adolescent boys
•Closely related to adult ankylosing spondylitis spectrum
Presentation
•Arthritis - asymmetric, predominantly lower limb (knees, ankles, hips); morning stiffness improving with activity
•Enthesitis - localised tenderness at tendon/ligament insertion sites (Achilles tendon at calcaneus is classic)
•Dactylitis - diffuse 'sausage digit' swelling from combined synovitis and tenosynovitis
•Sacroiliitis - buttock/low back pain in older adolescents; indicates axial involvement
•Anterior uveitis - typically acute, painful, red eye (unlike oligoarticular JIA where uveitis is asymptomatic); asymptomatic uveitis also occurs so annual ophthalmology screening required regardless
•Inflammatory bowel disease - associated (Crohn's and UC)
•Psoriasis - psoriatic plaques, nail pitting, onycholysis
Investigations
🥇 First-line
•HLA-B27 - positive in up to 80-90%; supports diagnosis, predicts axial progression
•ESR and CRP - elevated in active disease
•RF and ANA - typically negative (seronegative); excludes other JIA subtypes
•Plain X-ray - may be normal early; later shows erosions, sacroiliitis
🥈 Second-line
•MRI sacroiliac joints - detects early sacroiliitis before X-ray changes
•Ultrasound of entheses - confirms enthesitis with increased vascularity
Differential diagnosis
ERA vs key differentials
| Feature | ERA | Psoriatic arthritis | Reactive arthritis |
|---|---|---|---|
| Joints | Asymmetric lower limb; axial | Oligoarthritis incl. DIP joints; dactylitis | Large joint oligoarthritis |
| Key extra-articular | Enthesitis; acute uveitis; IBD | Psoriasis; nail changes; dactylitis | Urethritis/cervicitis; conjunctivitis/uveitis |
| Serology | HLA-B27 positive; RF/ANA negative | RF negative (seronegative) | RF negative; follows GI/GU infection |
| Skin | May have psoriasis | Psoriasis (may precede arthritis or follow) | None specific |
Management
🥇 First-line
•ibuprofen (or NSAID) - cornerstone of initial management; disease-modifying potential in ERA
•Physiotherapy and occupational therapy - maintain range of movement and function
•Intra-articular corticosteroid injection - for oligoarticular flares
🥈 Second-line
•sulfasalazine - preferred DMARD in ERA; used when NSAIDs insufficient
•methotrexate or leflunomide - alternative DMARDs for peripheral joint disease
🥉 Third-line
•TNF inhibitors (etanercept, adalimumab, infliximab) - for DMARD-refractory disease; effective for peripheral and axial disease
•Uveitis: topical corticosteroids and mydriatics for acute anterior uveitis; refractory cases - systemic DMARDs or biologics
Complications and prognosis
•Untreated anterior uveitis - band keratopathy, cataracts, glaucoma, irreversible visual loss
•Progression to ankylosing spondylitis - ERA is the JIA subtype most closely linked to adult axial spondyloarthritis
•Hip involvement in childhood - increased risk of hip replacement in adulthood; important prognostic marker